Andelyn Biosciences’ mission is to transform the lives of patients with genetic diseases

Founded as a spin out from Nationwide Children’s Hospital in 2020, Andelyn Biosciences leverages decades of expertise in gene therapy research and manufacturing. The company’s name is a tribute to two young gene therapy patients, Andrew and Evelyn, whose stories inspire Andelyn’s mission to make a meaningful impact on patients’ lives through advanced therapies. Andelyn Biosciences’ mission is to transform the lives of patients with genetic diseases by providing high quality, innovative gene therapy solutions. The company envisions a future where genetic disorders are effectively treated, and patients have access to life changing therapies.